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1. Introduction 
Nitric oxide (NO), compounds that contain the 
nitroso moiety and those which form and/or release 
NO have been found to activate guanylate cyclase 
(GC) and elevate tissue concentrations of guanosine 
cyclic 3’,5’-monophosphate (cyclic GMP) [l--5]. 
These observations were important because they 
revealed for the first time that chemical agents capable 
of elevating tissue levels of cyclic GMP could also 
activate GC in cell-free systems. Appreciable activa- 
tion of GC by acetylcholine and other muscarinic 
agents could never be demonstrated although tissue 
levels of cyclic GMP could be increased at least several 
fold. One mechanism by which NO activates GC may 
be through formation of an intermediate para- 
magnetic nitrosyl-ferrous heme complex, which 
presumably binds to and activates the enzyme [6,7]. 
Compounds uch as nitroprusside and N-methyl-N’- 
nitro-N-nitrosoguanidine (MNNG) activate GC by a 
mechanism which appears to be similar to that of 
NO, presumably by releasing NO in enzyme reaction 
mixtures and in intact cells [8,9]. 
Several inconsistent and inadequately explained 
observations have been reported with regard to the 
activation of GC by nitroso compounds, inhibition 
of such activation with heme proteins and the effects 
of dithiothreitol (DTT). First, hemoglobin was 
reported to inhibit activation of GC by NO and 
related compounds whereas methemoglobin was 
reported to be ineffective, and myoglobin effects 
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were variable [10,111. Second, DTT was found to be 
required for, or to enhance, nitroprusside activation 
of GC [3], and yet DTT inhibited MNNG activation 
of this enzyme system [11. 
The data here illustrate that: 
(1) Methemoglobin s indeed a potent inhibitor of 
NO activation of GC; 
(2) DTT is not required for nitroprusside activation 
of GC from tissue preparations relatively free of 
contaminating heme proteins but is required for 
crude preparations containing appreciable 
amounts of heme proteins; 
(3) DTT reverses methemoglobin blockade of GC 
activation by nitroso compounds but not by NO 
(4) DTT hastens the inactivation of MNNG. 
2. Materials and methods 
GC activity was determined in soluble fractions by 
measuring the formation of cyclic GMP from GTF 
(0.1 or 0.3 mM) in the presence of 3 mM Mg2’ by a 
modification (double column chromatographic isola- 
tion of cyclic GMP using Dowex 50-H’ followed with 
neutral alumina) of the methods in [ 121. Segments of
left descending and circumflex arteries and their 
branches were dissected from bovine hearts, cleaned 
of loosely adhering fat and connective tissue, minced 
finely and homogenized (20% w/v in 50 mM Tris- 
HCl (pH 7.4) at 4’C) by a two-step rocedure involv- 
ing: (1) cellular disruption with the aid of a Brinkmann 
Polytron (no. 3 setting for three 10 s intervals with 
30 s between); (2) grinding the resulting homogenate 
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with a Potter-Elvejhem, Teflon-glass tissue grinder. 
Homogenates were centrifuged at 110 000 X g for 
60 min at 4’C and supernatants were removed and 
stored at -7O’C. Soluble GC fractions from rat liver 
were prepared exactly as in [ 121. 
NO gas (99.9% pure) was obtained from 
Matheson Gas and dilutions were prepared just prior 
to use in O?-free purified Nz, using gas-tight syringes 
and glass containers. NO was delivered to GC reaction 
mixtures by direct injection into mixtures in open 
test tubes at exactly 1 min after initiation of enzyme 
reactions. An approximate stimation of the upper 
limit of the NO concentration i  reaction mixtures 
was made, taking into consideration i complete 
atmospheric mixing of NO in solution, an NO partition 
coefficient of 0.05, a fairly even distribution of NO in 
solution because of slow injections of a very fine 
stream of bubbles, and the equation PV = nRT. Calcu- 
lations indicated that 0.1 ~1 NO delivered to 1 .O ml 
aqueous medium at 37’C yielded a maximal concen- 
tration of 0.2 PM. Hemoglobin, methemoglobin, 
nitroprusside and DTT were obtained from Sigma, 
and MNNG was from Aldrich. 
3. Results and discussion 
NO activated bovine coronary arterial soluble GC 
70-fold over basal activity in the presence of Mgp 
(table 1) and the activation was concentration- 
dependent (not illustrated; 0.01-I ~1 NO activated 
GC 1 O-72-fold). NO reacts with and binds to ferrous 
heme [ 131 and one mechanism by which NO acti- 
vates GC may be by forming a paramagnetic nitrosyl- 
ferrous heme complex, which interacts with the 
enzyme [6,7]. Although NO forms nitrosyl-ferric 
heme with methemoglobin [ 13 1, this complex is dia- 
magnetic and this may account for its failure to activate 
GC (unpublished observations). Binding of NO to 
methemoglobin may also explain the inhibitory effect 
of this heme protein on NO activation of GC (table 1). 
Such an explanation may apply also to the hemo- 
globin tested in these experiments and in those 
reported by other investigators because commercially 
available crystalline hemoglobin is actually -75% 
methemoglobin, as stated on the product label. Met- 
hemoglobin (and hemoglobin) inhibited also the 
activation of GC by nitroprusside and MNNG (table 1). 
The mechanism by which methemoglobin hibits 
this activation may be the same as that suggested 
above for NO because both nitroprusside and MNNG 
activate GC probably by releasing NO [6,7]. 
DTT enhanced nitroprusside (32% increase) and 
MNNG (105% increase), but not NO, activation of 
bovine coronary arterial soluble GC (table 1). Further, 
although nitroprusside activated coronary arterial GC 
in the absence of DTT, nitroprusside failed to activate 
rat liver-soluble GC unless DTT was present in the 
Table 1 
Effects of dithicthreitol (DTT) and heme proteins on activation of coronary arterial 
soluble guanylate cyclase by nitroprusside (NP),N-methyl&‘-nitro- 
IV-nitrosoguanidine (MNNG) and nitric oxide (NO) 
Additions pmol cyclic GMP/min/mg proteina 
0.1 mM NP 0.1 mM MNNG 0.1 rl NO 
None 318214 408 f 19 592 f 38 
2mMDTT 419i21 836 f 31 471 f 32 
2 PM Methemoglobin 9i 1 9* 1 58+ 5 
2 PM Hemoglobin 12* 2 14* 2 120* 9 
2 mM DlT + 2 rM methemoglobin 386 f 17 778* 36 37* 4 
2 mM DTT’ + 2 rM hemoglobin 398 * 19 802 zt 24 85+ 7 
a Methemoglobin, hemoglobin, DTT, NP and MNNG were added to reaction mix- 
tures immediately prior to initiation of reactions with tissue; NO was added 1 min 
later (0.1 mM GTP, 3 mM Mg* and 150-174 pg tissue protein in 1.0 ml reaction 
vol. were employed). Basal GC activity was 8.4 * 0.5 pmol cyclic GMP/min/mg 
protein. Data represent he mean f SE, ~3-4 
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Table 2 
Effects of preincubation and dithiothreitol (DTT) on activation of rat liver 
soluble guanylate cyclase by nitroprusside (NP) and IV-methyl-N’-nitro- 
N-nitrosoguanidine (MNNG) 
Additions pmol cyclic GMP/min/mg proteina 
No pre- Preincubation at 0°C for 10 min 
incubationb 
-Tissuec +Tissued 
None 3 * 0.1 2* 0.1 3 + 0.2 
0.1 mM NP 10 f 0.4 12 + 0.3 12t 0.5 
0.1 mM NP + 2 mM DTT 626 + 23 683 + 21 654 f 18 
0.1 mM MNNG 880 + 29 1168 + 38 1097 f 31 
0.1 mM MNNG + 2 mM DTT 1446 f 37 8 f 0.3 1253 i 44 
l.O/.dNO 824 f 17 4 f 0.2 616 f 25 
l.OplNO+2mMDTT 857 f 26 4 * 0.1 812*33 
a Experiments were conducted with 3 mM Mg?+, 0.3 mM GTP and 600-700 pg 
protein in 1 .O ml reaction vol. Data represent the mean f SE, n=4 
b Agents were added together with tissue at start of incubation at 37°C 
c Agents were preincubated at0°C for 10 miu with substrate (GTP) but without 
tissue; tissue was added and samples were incubated at 37°C for 10 min 
d Agents were preincubated at0°C for 10 min with tissue but without substrate 
(GTP); GTP was added and samples were incubated at 37°C for 10 miu 
reaction mixture (table 2). In contrast, MNNG acti- taminated with these heme proteins (determined 
vation of rat liver soluble GC was observed in the spectrophotometrically). That is, the presence of 
absence of DTT and was enhanced by DTT (table 2; heme protein in the crude liver soluble fraction may 
no preincubation). These seemingly discrepant have accounted for the failure of nitroprusside to 
observations from the crude soluble fractions of the activate GC in the absence of DTT. DTT not only 
two different tissues studied may derive from the fact restored the activation of hepatic GC by nitroprusside 
that the crude soluble fraction from coronary artery (table 2) but also abolished the inhibitory effect of 
contained no measurable amounts of methemoglobin methemoglobin and hemoglobin on nitroprusside 
or hemoglobin whereas that from rat liver was con- . activation of coronary arterial GC (table 1). Thus, 
Table 3 
Inhibition of nitroprusside (NP) activation of coronary arterial soluble guanylate 
cyclase by rat liver soluble fraction and its reversal with dithiothreitol (DTT) 
Additions pmol cyclic GMP/mina 
Coronary LiverC 
arteryb Coronzry artery + liver 
None 2 f 0.1 3 f 0.2 3 * 0.2 
0.1 mM NP 76 f 6 2 f 0.1 12 * 0.8 
0.1 mM NP + 2 mM DTT 93 f 7 483 * 24 587 + 33 
a Experiments were conducted with 3 mM Mg*, 0.1 mM GTP and the amounts of 
protein indicated below, in 1 .O ml reaction vol. Data represent he mean f SE, u=9 
b Protein concentration in reaction mixture was 177-194 1(8 
c Protein concentration in reaction mixture was 643-677 pg 
d Total protein concentration in reaction mixtures was 820-871 pg 
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DTT restored the activation of hepatic GC by nitro- 
prusside presumably by abolishing the inhibitory 
effect of contaminating heme protein. Further, the 
addition of hepatic soluble fraction to coronary 
arterial soluble fraction abolished nitroprusside acti- 
vation of GC in the latter, an effect that was reversed 
with DTT (table 3). Again, the inhibitory effect of 
the rat liver fraction was probably due to the presence 
of contaminating heme protein, and this effect was 
abolished with DTT. In this regard, it may be of 
interest hat the sensitivity of the liver GC fraction to 
NO activation was 20-fold less than that of the 
coronary arterial fraction. For example, 0.1 1.11 NO 
failed to activate and 1 /_d NO activated liver GC to 
the same extent that 0.05 ~1 NO activated coronary 
arterial GC. 
Three observations may help to explain the 
mechanism by which DTT reversed the heme protein 
blockade of GC activation by nitroprusside and 
MNNG: 
(1) 
(2) 
(3) 
DTT enhanced MNNG and was required for 
nitroprusside activation of rat liver GC (table 2); 
Preincubation of MNNG with DTT for 10 min at 
0°C in the absence of tissue fraction abolished 
the capacity of MNNG to activate rat liver GC 
(table 2); 
DTT abolished heme protein blockage of nitro- 
prusside and MNNG, but not NO, activation of 
coronary arterial GC (table 1). 
These observations suggest that DTT may react with 
the nitroso compounds to promote release of NO, 
which may then overcome the inhibitory effect of 
the heme proteins. Moreover, MNNG may be more 
sensitive or more prone than nitroprusside to the 
capacity of DTT to release NO, as is suggested by the 
observations that MNNG, but not nitroprusside, 
activates rat liver GC in the absence of DTT (table 2). 
Preincubation of MNNG and DTT in the absence of 
tissue fraction resulted in the complete inactivation 
of MNNG within 10 min at 0°C (table 2). However, 
in the presence of tissue, preincubation of MNNG 
and DTT at 0°C did not destroy the reactivity of 
MNNG and complete capacity to activate GC at 37°C 
was maintained. If DTT causes NO release from 
MNNG, then the released NO must react with a 
soluble tissue component to form a relatively stable 
substance which is capable of activating GC during 
incubation at 37’C. Indeed, preincubation of NO in 
the absence of tissue resulted in inactivation of NO, 
whereas the inclusion of tissue in the preincubation 
restored the capacity of NO to activate GC (table 2). 
Evidence for the formation of a nitrosyl-ferrous 
heme complex by MNNG in crude hepatic soluble 
fractions at 4% has been obtained [11. Moreover, 
evidence for the release of NO from nitroso com- 
pounds by sulthydryl reducing agents exists [6,7]. 
DTT-induced NO release from nitroso compounds 
may also explain the findings (table 1) that DTT 
enhanced nitroprusside and MNNG, but not NO, 
activation of coronary arterial GC. 
Preincubation of nitroprusside and DTT and 0°C 
in the absence of tissue failed to inactivate nitro- 
prusside (table 2). This is in contrast o the findings 
with MNNG and the reasons for this difference are 
presently unknown. Possible xplanations include a 
much slower rate of release of NO from nitroprusside, 
and a direct nonenzymatic transfer of the nitroso 
moiety to ferrous heme in the presence of suitable 
reducing agents. Direct determination of the lability 
of the nitroso moiety on nitroprusside and MNNG 
in reaction mixtures must be made in order to answer 
this question. In any event, such an interpretation 
may be used to explain: 
(1) 
(2) 
(3) 
The failure of nitroprusside to activate rat liver 
GC in the absence of DTT (table 2); 
The lesser degree of enhancement by DTT of 
nitroprusside than of MNNG activation of coro- 
nary arterial GC (table 1); 
The failure of DTT to reverse the heme protein 
blockade of GC activation by NO (table 1). 
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